Glitazone Drug May Cut Lupus Heart Risk

(MedPage Today) -- A way to reduce cardiovascular (CV) risk in people with systemic lupus erythematosus (SLE) without interfering with immune mechanisms could be near at hand, results of a clinical trial suggested In a study involving 80 SLE patients...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news